ISRCTN66478538CompletedNot Applicable
Intra-operative administration of taurolidine reduces level of interleukin-1 beta rather than povidone-iodine in patients with colon, gastric, and pancreatic cancer. A clinical prospective randomised multicenter trial.
Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)0 sites120 target enrollmentStarted: February 17, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Open resection of colon, gastric, or pancreatic cancer
- •2. American Society of Anesthesiologists (ASA) I-III classification
- •3. Histopathological R0-resection
Exclusion Criteria
- •1. Complete ileus
- •2. ASA IV classification
- •3. Histopathological R1- or R2-resection
- •4. Unknown intra-operative metastasis, peritoneal carcinomatosis, intra-abdominal abscess, sepsis or clinically relevant organ failure
- •5. Apparent coagulopathy
Investigators
Similar Trials
Completed
Phase 3
Perioperative administration of Tapentadol – tolerance, safety and effectson postoperative recovery and quality of life.(PATENT)Randomized, controlled study to compare the analgesic therapy withtapentadol compared to pure opioid receptor agonistsHysterectomy with ASA 1-3R52.9Pain, unspecifiedDRKS00005432Philipps-Universität Marburg121
Active, not recruiting
Phase 1
Standard-armed controlled study to assess the impact of tapentadol administration after hysterectomy, prostatektomy or nephrektomie on quality of life and pain management as well as on safety and tolerability in comparison to a conventional pain therapy with morphine using a historical control group.Hysterectomy with ASA 1-3, Prostatectomy with ASA 1-3, Nephrectomy with ASA 1-3MedDRA version: 14.1Level: PTClassification code 10021151Term: HysterectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10029116Term: NephrectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10061916Term: ProstatectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-004585-18-DEPhilipps-Universität Marburg
Completed
Not Applicable
sing taurolidine to attenuate the surgically-induced endotoxaemia and the subsequent inflammatory response in patients with primary non-metastatic colon cancerCancerColon cancerISRCTN77829558Geistlich Pharma AG (Switzerland)60
Recruiting
Phase 3
Assessment of TauroLock™ in port catheterIRCT20201107049296N4Iran University of Medical Sciences72
Active, not recruiting
Not Applicable
Evaluation of intralesional administration of rituximab for treatment of orbital lymphoma - NDEUCTR2007-007799-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI